https://www.selleckchem.com/pr....oducts/sulfatinib.ht
There was no clinically meaningful change in any of the primary or secondary outcome measures including VO2peak, 12 min walk test and muscle biopsy to look for a change in the number of phosphorylase positive fibres between baseline and 6 months of treatment. Although this was a small open label feasibility study, it suggests that a larger randomised controlled study of VPA, may not be worthwhile. In recent studies, microRNAs (mi-RNAs) have been shown to play an important role in psoriasis pathogenesis. However, studies evaluating mi
Like
Comment
Share
